In 2001, Mallinckrodt purchased a prescription medication called Acthar Gel from pharmaceutical company Sanofi-Aventis. Pursuant to the purchase agreement, Mallinckrodt paid Sanofi $100,000 up front ...

"In Specialty Brands, we achieved net sales growth, driven by increasing Acthar Gel sales as demand continued to stabilize and by meaningful progress in our ongoing launch of Terlivaz ®, which is now ...

Treatment with Remicade (infliximab) is generally effective for controlling sarcoidosis when it affects the nervous system or liver, but patients whose disease affects the skin or skeletal system aren ...

NEW YORK, April 25 (Reuters) - Mallinckrodt's bankruptcy permitted the drug company to end a perpetual royalty agreement with Sanofi-Aventis involving the best-selling medication Acthar ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/mallinckrodt-plc-reports-fourth-quarter-and-fiscal-year-2023-financial-results ...

Exceeds High End of Guidance Range on Net Sales and Adjusted EBITDA for Fiscal Year Received U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application for Acthar ® Gel ...

Kerry Wong lives in Westchester, New York, with her husband, the boy next door she had a crush on since she was a child. She was diagnosed with sarcoidosis in 2015 after an eight-year search for ...